Chronic Kidney Failure: Clinical Trials

10 trials for Chronic Kidney Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 terminated, 2 unknown. 10 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Completed 6, Terminated 2, Unknown 2
Phase 13Completed 1, Terminated 1, Unknown 1

Follow Chronic Kidney Failure: new trials by email Literature Review of Chronic Kidney Failure trials Research Report on Chronic Kidney Failure

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes?
Normothermic machine perfusion - Kidney Transplant Failure, Chronic Kidney Failure
Phase 2UnknownErasmus Medical Center802021-05-012024-05-07
Traditional Chinese Medicine (TCM) Colon Dialysis Treats Non-dialysis End-Stage Kidney Disease
colon lotion - Chronic Kidney Failure, End-Stage Kidney Disease
Phase 1 / Phase 2UnknownPang Peng202017-05-152018-05-30
An Innovative Virtually Supervised Exercise for Dialysis Patients
Sensor-based interactive exercise (game-based exercise), Non-technology foot and ankle exercise program - Diabetes, Chronic Kidney Failure
Phase 2CompletedBaylor College of Medicine1002016-11-062019-05-06
Effect of Mixed On-line Hemodiafiltration on Circulating Markers of Inflammation and Vascular Dysfunction
mixed on-line hemodiafiltration, High flux bicarbonate dialysis - Chronic Kidney Failure, Dialysis Related Complication
Phase 1 / Phase 2CompletedA.O.U. Città della Salute e della Scienza302014-02-032017-06-29
Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients
efalizumab - Kidney Transplantation, Chronic Kidney Failure
Phase 1 / Phase 2TerminatedEmory University52007-05-012014-01-27
Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia
Fermagate, Sevelamer HCl - Chronic Kidney Failure
Phase 2CompletedIneos Healthcare Limited642007-02-012009-08-10
An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate
Fermagate - Chronic Kidney Failure
Phase 2TerminatedIneos Healthcare Limited442006-07-012009-08-10
Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients
Fermagate, Placebo - Chronic Kidney Failure
Phase 2CompletedIneos Healthcare Limited1112006-03-012009-08-10
A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis
PEG-hirudin - Chronic Kidney Failure, Vascular Graft Occlusion
Phase 2CompletedSpeedel Pharma Ltd.2602003-11-012007-10-05
Kidney Transplant for HIV-Infected Patients in Renal Failure
immunosuppressive regimen designed to complement HAART - Chronic Kidney Failure, HIV Infection
Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)102001-01-012008-03-04

Narrower conditions

Kidney Failure, Chronic (10)  ·  Hyperphosphatemia (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Diabetes Mellitus (1)  ·  Graft Occlusion, Vascular (1)  ·  HIV Infections (1)  ·  Motor Activity (1)

Broader conditions

Chronic Disease (10)  ·  Disease Attributes (10)  ·  Female Urogenital Diseases (10)  ·  Female Urogenital Diseases and Pregnancy Complications (10)  ·  Kidney Diseases (10)  ·  Male Urogenital Diseases (10)  ·  Pathologic Processes (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Renal Insufficiency (10)  ·  Renal Insufficiency, Chronic (10)  ·  Urogenital Diseases (10)  ·  Urologic Diseases (10)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Phosphorus Metabolism Disorders (2)

Interventions

iron-magnesium hydroxycarbonate (3)  ·  Sevelamer (1)  ·  efalizumab (1)  ·  polyethyleneglycol-hirudin (1)

Sponsors

Ineos Healthcare Limited (3)  ·  A.O.U. Città della Salute e della Scienza (1)  ·  Baylor College of Medicine (1)  ·  Emory University (1)  ·  Erasmus Medical Center (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Pang Peng (1)  ·  Speedel Pharma Ltd. (1)

Countries

United States (5)  ·  United Kingdom (3)  ·  China (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Qatar (1)

Top investigators

Simon Roe, MB ChB (2)  ·  Bao Kun (1)  ·  Chen X Yin, Ph.D (1)  ·  Jessica M Mann, MD, PhD (1)  ·  Kenneth A Newell, MD, PhD (1)  ·  Maarten Taal, MBChB MD FRCP (1)  ·  Pang Peng (1)

Results publications

PMID 40576086, PMID 30441843, PMID 34708171, PMID 38979743, PMID 40278798